Kodiak Sciences Inc

NASDAQ:KOD 4:00:00 PM EDT

2.44

+0.06 (+2.52%)

7:13:30 PM EDT: $2.36 -0.08 (-3.28%)

Kodiak Sciences Inc Stock, NASDAQ:KOD

1200 Page Mill Road, Palo Alto, California 94304

United States of America

Phone: +1.650.281.0850

Number of Employees: 111

http://www.kodiak.com

Description

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.